OBIO

MKT CAP:$229M

Orchestra BioMed Holdings Inc.

Market Cap

$229M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.90-$0.41 (-9.51%)

Jun 5, 2026

52W High $5.3552W Low $2.35

Company Details

Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substa...

CEO

—

IPO Date

Aug 4, 2020

Website

www.orchestrabiomed.com

Key Metrics TTM

Revenue

$33M

+1033.9% YoY

Net Income

-$55M

EPS (Diluted)

Free Cash Flow

-$55M

Revenue / Share

$0.85

Gross Margin

99.3%

Operating Margin

-168.0%

Net Margin

-167.0%

FCF Margin

-168.3%

P/S

7.0x

P/E

Earnings Reports

Q2 2026

Aug 6, 2026

PENDING

Q1 2026

May 12, 2026

$110.0K-87.3%

FY 2025

Mar 12, 2026

$33M+1169.2%

Q4 2025

Mar 12, 2026

$31M+12120.2%

Q3 2025

Nov 10, 2025

$861.0K-12.8%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee